U.S. markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
600.75+9.78 (+1.65%)
At close: 4:03PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 5/14/2021
Current
3/31/202112/31/20209/30/20206/30/20203/31/2020
Market Cap (intraday) 5
17.80B17.04B17.35B15.34B13.33B10.40B
Enterprise Value 3
17.00B16.28B16.84B14.95B12.94B9.93B
Trailing P/E
4.354.534.997.998.646.02
Forward P/E 1
45.4547.6249.26N/AN/AN/A
PEG Ratio (5 yr expected) 1
3.81N/A1.06N/AN/AN/A
Price/Sales (ttm)
6.606.777.396.785.854.58
Price/Book (mrq)
1.661.721.972.092.131.81
Enterprise Value/Revenue 3
6.2922.3921.3323.1024.1017.38
Enterprise Value/EBITDA 7
3.1112.2315.058.6710.0610.59

Trading Information

Stock Price History

Beta (5Y Monthly) 0.82
52-Week Change 327.43%
S&P500 52-Week Change 341.30%
52 Week High 3689.00
52 Week Low 3425.43
50-Day Moving Average 3607.77
200-Day Moving Average 3591.16

Share Statistics

Avg Vol (3 month) 3168.02k
Avg Vol (10 day) 3142.01k
Shares Outstanding 524.69M
Implied Shares Outstanding 629.76M
Float 21.27M
% Held by Insiders 114.34%
% Held by Institutions 181.21%
Shares Short (Apr 29, 2021) 4571.87k
Short Ratio (Apr 29, 2021) 44.65
Short % of Float (Apr 29, 2021) 42.70%
Short % of Shares Outstanding (Apr 29, 2021) 41.92%
Shares Short (prior month Mar 30, 2021) 4539.06k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Mar 07, 2002

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 151.73%
Operating Margin (ttm)18.91%

Management Effectiveness

Return on Assets (ttm)2.82%
Return on Equity (ttm)48.49%

Income Statement

Revenue (ttm)2.7B
Revenue Per Share (ttm)90.76
Quarterly Revenue Growth (yoy)27.10%
Gross Profit (ttm)1.44B
EBITDA 647.85M
Net Income Avi to Common (ttm)4.1B
Diluted EPS (ttm)135.87
Quarterly Earnings Growth (yoy)42.50%

Balance Sheet

Total Cash (mrq)1.02B
Total Cash Per Share (mrq)34.27
Total Debt (mrq)220.2M
Total Debt/Equity (mrq)2.08
Current Ratio (mrq)3.57
Book Value Per Share (mrq)356.45

Cash Flow Statement

Operating Cash Flow (ttm)626.13M
Levered Free Cash Flow (ttm)484.41M